Cost-effectiveness of the 2014 US Preventive Services Task Force (USPSTF) Recommendations for Intensive Behavioral Counseling Interventions for Adults With Cardiovascular Risk Factors

被引:12
|
作者
Lin, Ji [1 ]
Zhuo, Xiaohui [2 ]
Bardenheier, Barbara [1 ,3 ]
Rolka, Deborah B. [1 ]
Gregg, W. Edward [1 ]
Hong, Yuling [4 ]
Wang, Guijing [4 ]
Albright, Ann [1 ]
Zhang, Ping [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA
[2] Merck Res Lab, N Wales, PA USA
[3] Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA USA
[4] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA USA
关键词
ACTIVITY PROMOTION PROGRAMS; LIFETIME HEALTH OUTCOMES; PHYSICAL-ACTIVITY; DIABETES PREVENTION; DISEASE PREVENTION; HEART-DISEASE; COMBINED DIET; VALIDATION; MODEL;
D O I
10.2337/dc16-1186
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE In 2014, the U.S. Preventive Services Task Force (USPSTF) recommended behavioral counseling interventions for overweight or obese adults with the following known cardiovascular disease risk factors: impaired fasting glucose (IFG), hypertension, dyslipidemia, or metabolic syndrome. We assessed the long-term costeffectiveness (CE) of implementing the recommended interventions in the U.S. RESEARCH DESIGN AND METHODS We used a disease progression model to simulate the 25-year CE of the USPSTF recommendation for eligible U.S. adults and subgroups defined by a combination of the risk factors. The baseline population was estimated using 2005-2012 National Health and Nutrition Examination Survey (NHANES). The cost and effectiveness of the intervention were obtained from systematic reviews. Incremental CE ratios (ICERs), measured in cost/quality-adjusted life-year (QALY), were used to assess the CE of the intervention compared with no intervention. Future QALYs and costs (reported in 2014 U.S. dollars) were discounted at 3%. RESULTS We estimated that similar to 98 million U.S. adults (44%) would be eligible for the recommended intervention. Compared with no intervention, the ICER of the intervention would be $13,900/QALY. CE varied widely among subgroups, ranging from a cost saving of $302 per capita for those who were obese with IFG, hypertension, and dyslipidemia to a cost of $103,200/QALY in overweight people without these conditions. CONCLUSIONS The recommended intervention is cost effective based on the conventional CE threshold. Considerable variation in CE across the recommended subpopulations suggests that prioritization based on risk level would yield larger total health gains per dollar spent.
引用
收藏
页码:640 / 646
页数:7
相关论文
共 50 条
  • [21] Cost-effectiveness analyses of colorectal cancer screening: A systematic review for the US preventive services task force
    Pignone, M
    Saha, S
    Hoerger, T
    Mandelblatt, J
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (02) : 96 - 104
  • [22] Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening
    Toumazis, Iakovos
    de Nijs, Koen
    Cao, Pianpian
    Bastani, Mehrad
    Munshi, Vidit
    ten Haaf, Kevin
    Jeon, Jihyoun
    Gazelle, G. Scott
    Feuer, Eric J.
    de Koning, Harry J.
    Meza, Rafael
    Kong, Chung Yin
    Han, Summer S.
    Plevritis, Sylvia K.
    JAMA ONCOLOGY, 2021, 7 (12) : 1833 - 1842
  • [23] Behavioral Counseling Interventions for Healthy Weight and Weight Gain in Pregnancy: US Preventive Services Task Force Recommendation Statement
    Davidson, Karina W.
    Barry, Michael J.
    Mangione, Carol M.
    Cabana, Michael
    Caughey, Aaron B.
    Davis, Esa M.
    Donahue, Katrina E.
    Doubeni, Chyke A.
    Krist, Alex H.
    Kubik, Martha
    Li, Li
    Ogedegbe, Gbenga
    Pbert, Lori
    Silverstein, Michael
    Simon, Melissa
    Stevermer, James
    Tseng, Chien-Wen
    Wong, John B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (20): : 2087 - 2093
  • [25] Estimated Impact of US Preventive Services Task Force Recommendations on Use and Cost of Statins for Cardiovascular Disease Prevention
    Quyen Ngo-Metzger
    Samuel H. Zuvekas
    Arlene S. Bierman
    Journal of General Internal Medicine, 2018, 33 : 1317 - 1323
  • [26] Estimated Impact of US Preventive Services Task Force Recommendations on Use and Cost of Statins for Cardiovascular Disease Prevention
    Ngo-Metzger, Quyen
    Zuvekas, Samuel H.
    Bierman, Arlene S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (08) : 1317 - 1323
  • [27] US Preventive Services Task Force (USPSTF) recommendations on PSA screening (PSAS) for prostate cancer (PC): Are they justified?
    Strauss, Gary M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Screening and Interventions for Social Risk Factors Technical Brief to Support the US Preventive Services Task Force
    Eder, Michelle
    Henninger, Michelle
    Durbin, Shauna
    Iacocca, Megan O.
    Martin, Allea
    Gottlieb, Laura M.
    Lin, Jennifer S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (14): : 1416 - 1428
  • [29] Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement
    Moyer, Virginia A.
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (01) : 59 - U103
  • [30] Behavioral Counseling to Prevent Skin Cancer: A Systematic Review for the US Preventive Services Task Force
    Lin, Jennifer S.
    Eder, Michelle
    Weinmann, Sheila
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (03) : 190 - +